Drug-eluting stents in the management of peripheral arterial disease.

Vasc Health Risk Manag · 2008 · PMC2515416 · PMID 18827906

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The same highly significant difference in 6-month angiographic outcome between the Cypher ® and the nondrug-eluting BX Sonic ® stent (Cordis, Miami, FL, USA) was confirmed by Scheinert and colleagues (2006) in a nonrandomized controlled trial.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.